🇺🇸 triamcinolonacetonide in United States

85 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 85

Most-reported reactions

1. Diarrhoea — 13 reports (15.29%)
2. Confusional State — 10 reports (11.76%)
3. Hallucination — 10 reports (11.76%)
4. Asthenia — 8 reports (9.41%)
5. General Physical Health Deterioration — 8 reports (9.41%)
6. Hypocalcaemia — 8 reports (9.41%)
7. Cystitis — 7 reports (8.24%)
8. Dyspnoea — 7 reports (8.24%)
9. Hypomagnesaemia — 7 reports (8.24%)
10. Pain In Extremity — 7 reports (8.24%)

Source database →

Frequently asked questions

Is triamcinolonacetonide approved in United States?

triamcinolonacetonide does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for triamcinolonacetonide in United States?

Assiut University is the originator. The local marketing authorisation holder may differ — check the official source linked above.